Affinia Therapeutics Revenue and Competitors

Claim your profile

Boston, MA USA



Total Funding



Estimated Revenue & Valuation

  • Affinia Therapeutics's estimated annual revenue is currently $15.3M per year.(i)
  • Affinia Therapeutics's estimated revenue per employee is $155,000
  • Affinia Therapeutics's total funding is $170M.

Employee Data

  • Affinia Therapeutics has 99 Employees.(i)
  • Affinia Therapeutics grew their employee count by 38% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

We are working to methodically engineer durable gene therapies for people with devastating diseases.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Affinia Therapeutics News

2022-04-20 - BGLTQ Alumni Reflect on Harvard and the Workplace in HBS ...

Cobb, who is the Chief Business Officer at Affinia Therapeutics, described their time at Harvard Business School as a “straight cocktail...

2022-03-22 - Affinia Therapeutics Strengthens Leadership Team with ...

Affinia Therapeutics' proprietary Affinia Rationally-designed Therapeutics (ART) platform consists of three pillars intended to synergistically...

2021-09-08 - Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment of Neurologic and Neuro-oncologic Diseases supported by Multi-Year Manufacturing Agreement with Lonza Group

Indications include metachromatic leukodystrophy, a rare, progressive, and fatal disease affecting the nervous system, and brain metastases secondary to HER2+ breast cancer, a common and deadly form of cancer – Affinia Therapeutics to use its proprietary technologies and capsids with improved pr ...

2021-05-04 - Affinia Therapeutics secures $110M

Affinia Therapeutics has raised a $110 million Series B co-led by EcoR1 Capital and Farallon Capital Management. Founded in 2019 and based in the Boston area, the company is developing gene therapies for diseases affecting the central nervous system and muscles. It was valued at $110 million in ...

2021-05-04 - Affinia Therapeutics raises $110 million for gene therapy treatments

Affinia Therapeutics, a Waltham-based biotech working on gene therapies to treat diseases using technology developed at Massachusetts Eye and Ear, said Monday it has raised $110 million in a new venture capital round. The company, which was founded in 2019 based on work pioneered by Luk Vandenb ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding